How a Diverse Research Ecosystem Has Generated New Rehabilitation Technologies: Review of NIDILRR’s Rehabilitation Engineering Research Centers

Over 50 million United States citizens (1 in 6 people in the US) have a developmental, acquired, or degenerative disability. The average US citizen can expect to live 20% of his or her life with a disability. Rehabilitation technologies play a major role in improving the quality of life for people with a disability, yet widespread and highly challenging needs remain. Within the US, a major effort aimed at the creation and evaluation of rehabilitation technology has been the Rehabilitation Engineering Research Centers (RERCs) sponsored by the National Institute on Disability, Independent Living, and Rehabilitation Research. As envisioned at their conception by a panel of the National Academy of Science in 1970, these centers were intended to take a “total approach to rehabilitation”, combining medicine, engineering, and related science, to improve the quality of life of individuals with a disability. Here, we review the scope, achievements, and ongoing projects of an unbiased sample of 19 currently active or recently terminated RERCs. Specifically, for each center, we briefly explain the needs it targets, summarize key historical advances, identify emerging innovations, and consider future directions. Our assessment from this review is that the RERC program indeed involves a multidisciplinary approach, with 36 professional fields involved, although 70% of research and development staff are in engineering fields, 23% in clinical fields, and only 7% in basic science fields; significantly, 11% of the professional staff have a disability related to their research. We observe that the RERC program has substantially diversified the scope of its work since the 1970’s, addressing more types of disabilities using more technologies, and, in particular, often now focusing on information technologies. RERC work also now often views users as integrated into an interdependent society through technologies that both people with and without disabilities co-use (such as the internet, wireless communication, and architecture). In addition, RERC research has evolved to view users as able at improving outcomes through learning, exercise, and plasticity (rather than being static), which can be optimally timed. We provide examples of rehabilitation technology innovation produced by the RERCs that illustrate this increasingly diversifying scope and evolving perspective. We conclude by discussing growth opportunities and possible future directions of the RERC program

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

The expanding pandemic of coronavirus disease 2019 (COVID-19) requires the development of safe, efficacious and fast-acting vaccines. Several vaccine platforms are being leveraged for a rapid emergency response1. Here we describe the development of a candidate vaccine (YF-S0) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that uses live-attenuated yellow fever 17D (YF17D) vaccine as a vector to express a noncleavable prefusion form of the SARS-CoV-2 spike antigen. We assess vaccine safety, immunogenicity and efficacy in several animal models. YF-S0 has an excellent safety profile and induces high levels of SARS-CoV-2 neutralizing antibodies in hamsters (Mesocricetus auratus), mice (Mus musculus) and cynomolgus macaques (Macaca fascicularis), and—concomitantly—protective immunity against yellow fever virus. Humoral immunity is complemented by a cellular immune response with favourable T helper 1 polarization, as profiled in mice. In a hamster model2 and in macaques, YF-S0 prevents infection with SARS-CoV-2. Moreover, a single dose conferred protection from lung disease in most of the vaccinated hamsters within as little as 10 days. Taken together, the quality of the immune responses triggered and the rapid kinetics by which protective immunity can be attained after a single dose warrant further development of this potent SARS-CoV-2 vaccine candidate

Resonant Inelastic X-ray Scattering (RIXS) Studies in Chemistry : Present and Future

This chapter illustrates how resonant inelastic x-ray scattering (RIXS) is used to address questions in chemistry, with special focus on the electronic structure and catalytic activity of first row transition metals. RIXS is a two-photon process that is the x-ray equivalent of resonance Raman spectroscopy. The final states correspond to vibrational, valence electronic or even core excitations. In addition to the advantages of a local element-selective x-ray spectroscopic probe, RIXS gives new information compared to single-photon x-ray absorption and x-ray emission experiments. Metal L-edge RIXS shows intense metal-centered ligand- field transitions, even in cases where they are spin or parity forbidden in optical absorption spectroscopy. By selecting different resonances by appropriately tuning the incident energy, it is possible to isolate different ligand-field and charge-transfer transitions. The observation of a large number of electronic states that can be properly assigned, sometimes with the help of theoretical methods, gives novel opportunities to quantify metal-ligand interactions and their contributions to reactivity. RIXS in the K pre-edge can be used to obtain L- and M-edge like spectra including insight into charge-transfer excitations all with the advantages of a hard x-ray probe. Finally, it is shown how time-resolved RIXS down to the femtosecond timescale probes the orbitals of transient reaction intermediates. The usefulness of RIXS in chemistry is shown for a diverse set of systems, including coordination complexes, metal enzymes, and nanoparticles